NR3C2 and hydrops fetalis: With the continuous updating of evidence-based therapies in recent years, Ace inhibitors/Angiotensin II receptor antagonists, β-receptor blockers, and aldosterone receptor antagonists have become common drugs for HF, which can effectively improve clinical symptoms and patients’ life quality.